1-(4-Aminophenyl)methanesulfonamide → (4-{4-[Methyl-(1-methyl-2-phenethylamino-1H-benzoimidazol-5-yl)-amino]-pyrimidin-2-ylamino}-phenyl)-methanesulfonamide hydrochloride
Reaction equation
[Cl:1][C:2]1[N:7]=[C:6]([N:8]([CH3:28])[C:9]2[CH:27]=[CH:26][C:12]3[N:13]([CH3:25])[C:14]([NH:16][CH2:17][CH2:18][C:19]4[CH:24]=[CH:23][CH:22]=[CH:21][CH:20]=4)=[N:15][C:11]=3[CH:10]=2)[CH:5]=[CH:4][N:3]=1.[NH2:29][C:30]1[CH:35]=[CH:34][C:33]([CH2:36][S:37]([NH2:40])(=[O:39])=[O:38])=[CH:32][CH:31]=1>>[ClH:1].[CH3:28][N:8]([C:9]1[CH:27]=[CH:26][C:12]2[N:13]([CH3:25])[C:14]([NH:16][CH2:17][CH2:18][C:19]3[CH:24]=[CH:23][CH:22]=[CH:21][CH:20]=3)=[N:15][C:11]=2[CH:10]=1)[C:6]1[CH:5]=[CH:4][N:3]=[C:2]([NH:29][C:30]2[CH:35]=[CH:34][C:33]([CH2:36][S:37]([NH2:40])(=[O:38])=[O:39])=[CH:32][CH:31]=2)[N:7]=1Participants
3
Reactant 2
Product 1
Procedure
The title compound was prepared following the procedure of example 1 with N5-(2-Chloro-pyrimidin-4-yl)-1,N5-dimethyl-N2-phenethyl-1H-benzoimidazole-2,5-diamine (98 mg, 0.25 mmol) and (4-amino-phenyl)-methanesulfonamide (46 mg, 0.25 mmol) as a white solid (37 mg, 26%). 1H NMR (300 MHz, d6-DMSO) δ 9.17 (s, 1H), 7.76-7.78 (m, 3H), 7.21-7.34 (m, 8H), 7.19 (s, 1H), 7.13 (d, J=1.8 Hz, 1H), 7.00 (br s, 1H), 6.84 (dd, J=8.1 and 1.5 Hz, 1H), 6.77 (s, 2H), 5.63 (d, J=6.0 Hz, 1H), 4.16 (s, 2H), 3.54-3.61 (m, 2H), 3.52 (s, 3H), 3.45 (s, 3H), 2.92-2.97 (m, 2H) ppm. MS (ESI) m/z=543 [M+H]+.
Sources & evidence
- ORD record
- ord-a99ffc950416467f9960f578f634081a
- Source dataset
- uspto-grants-2008_03
- Patent number
- US07338959B2
Reaction notes
Loading…